- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06613958
Older Adults Exercising On Time (ON TIME)
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Zuid-Holland
-
Leiden, Zuid-Holland, Netherlands, 2333ZA
- Leiden University Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Aged between 60 and 80 years old
- Retired
- Long lasting sleep problems (as assessed by a the screening questionnaire administered telephonically and by the ISI which will be filled out during the screening visit)
- Access to and ability to use a smart phone (Android or Apple)
Exclusion Criteria:
- Currently employed or working
- Extreme sleep chronotypes (measured by the Munich chronotype questionnaire)
- Participation in any sort of fasting regimen (e.g. intermitted fasting or Ramadan)
- Experienced recent (<6 months) adverse life events (e.g., death of partner)
- Abnormal values in glucose metabolism, thyroid, liver or kidney function, or inflammation markers that after examination of the study doctor need immediate attention of a general practitioner or specialist.
- Diagnosed clinical depression
- Diagnosed neurodegenerative diseases (e.g. dementia or Parkinson's disease)
- Diagnosed sleep apnoea
- Diagnosed restless legs syndrome
- Use of beta-adrenergic blocking agents
- Use of sleep medication*
- Injuries or other severe physical conditions (such as active arthrosis) that inhibits physical activity
- Travelled across time zones one week prior to start of study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Group 1
Order of interventions: Sedentary - Active morning - Active Evening
|
The investigators will compare our interventions to a 14-day period of sedentary behavior, during which the participant will refrain from any moderate to vigorous exercise.
Next, participants will participate in two interventions consisting each of a 14-day physical activity regimen.
The active morning and active evening interventions are equal in content.
Both groups will be instructed to refrain from any moderate to vigorous exercise for the rest of the day.
Per intervention, a total of eight Vitality Club training session comprising of a combination of aerobic endurance training and resistance exercise training will be given by a trained sports coach or physical therapist specialized in geriatric physical therapy.
During the weekends, participants will be asked to perform a 'relative rest' session with some light activity during the training time window of the intervention arm.
Other Names:
|
|
Other: Group 2
Order of the interventions: Sedentary - Active Evening - Active Morning
|
The investigators will compare our interventions to a 14-day period of sedentary behavior, during which the participant will refrain from any moderate to vigorous exercise.
Next, participants will participate in two interventions consisting each of a 14-day physical activity regimen.
The active morning and active evening interventions are equal in content.
Both groups will be instructed to refrain from any moderate to vigorous exercise for the rest of the day.
Per intervention, a total of eight Vitality Club training session comprising of a combination of aerobic endurance training and resistance exercise training will be given by a trained sports coach or physical therapist specialized in geriatric physical therapy.
During the weekends, participants will be asked to perform a 'relative rest' session with some light activity during the training time window of the intervention arm.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Insomnia severity
Time Frame: 4 times in total: at baseline T-3 (T= week), at T2 , T5, and at T8 (endline).
|
Score on Insomnia Severity Index (ISI).
Participants will be asked to fill out the ISI questionnaire (Dutch version) The ISI questionnaire consists of 7 questions and outcomes include: 'No clinically significant insomnia (0-7 points)', 'Subthreshold insomnia (8-14 points)', 'Moderate severity clinical insomnia (15-21 point), and 'Severe clinical insomnia (22-28 points)'.
|
4 times in total: at baseline T-3 (T= week), at T2 , T5, and at T8 (endline).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dim light melatonin onset (DLMO)
Time Frame: 3 times in total: two weeks, five weeks and eight weeks after baseline.
|
Participants will be asked to perform/collect 7 buccal swabs in a time range of 5 hours prior to bedtime to 1 hour after bedtime to measure the melatonin pattern DLMO one evening at the end of each intervention.
This measurement will be done according to the standard protocol from Chrono@Work (Groningen, The Netherlands) in dim light conditions.
Participants will be carefully instructed beforehand on the procedure.
Melatonin levels will be shown in Pg/ml
|
3 times in total: two weeks, five weeks and eight weeks after baseline.
|
|
Ecological monitoring assessment
Time Frame: 3 periods in total of one week each: the second week, the fifth week and the eighth week.
|
During the measurement week, participants will be asked to fill out the eEMA questionnaire in the Leuven mPath app 4 times a day on set times (between 7-9 AM, 12-2 PM, 4-6 PM and 8-10 PM).
Participants will receive a pop-up on their smartphones and will have a window of 2 hours to fill in the questionnaire.
The questionnaire consists of multiple questions that gather information on current mood/feelings divided into multiple dimensions: positive affectivity, negative affectivity, energetic arousal and cognition.
A visual analogue scale will be used to answer the questions.
To minimize the burden of this repeated questionnaire, the time needed to fill out the questionnaire is limited to approximately 3 minutes.
|
3 periods in total of one week each: the second week, the fifth week and the eighth week.
|
|
Sleep quality - sleep duration
Time Frame: 3 periods in total of 2 weeks each: weeks 1-2 , weeks 4-5, and weeks 7-8.
|
Objective sleep quality will be monitored with the Withings Sleep Analyzer (Withings, Issy-les-Moulineaux, France) . Prior to the study, the Withings Sleep Analyzer will be installed in the participants bed. A smart phone is required to set-up the device and the devices must be connected to a Wi-Fi to be able to send data to the cloud. After set-up no link to the smartphone is required. The device must be connected to power. Sleep duration, pattern of and duration spent in different sleep stages (deep, REM, and light sleep), sleep latency, sleep efficiency, and sleep regularity. |
3 periods in total of 2 weeks each: weeks 1-2 , weeks 4-5, and weeks 7-8.
|
|
Sleep quality - sleep latency
Time Frame: 3 periods in total of 2 weeks each: weeks 1-2 , weeks 4-5, and weeks 7-8.
|
Objective sleep quality will be monitored with the Withings Sleep Analyzer (Withings, Issy-les-Moulineaux, France) . Prior to the study, the Withings Sleep Analyzer will be installed in the participants bed. A smart phone is required to set-up the device and the devices must be connected to a Wi-Fi to be able to send data to the cloud. After set-up no link to the smartphone is required. The device must be connected to power. Sleep duration, pattern of and duration spent in different sleep stages (deep, REM, and light sleep), sleep latency, sleep efficiency, and sleep regularity. |
3 periods in total of 2 weeks each: weeks 1-2 , weeks 4-5, and weeks 7-8.
|
|
Sleep quality - sleep stages
Time Frame: 3 periods in total of 2 weeks each: weeks 1-2 , weeks 4-5, and weeks 7-8.
|
Objective sleep quality will be monitored with the Withings Sleep Analyzer (Withings, Issy-les-Moulineaux, France) . Prior to the study, the Withings Sleep Analyzer will be installed in the participants bed. A smart phone is required to set-up the device and the devices must be connected to a Wi-Fi to be able to send data to the cloud. After set-up no link to the smartphone is required. The device must be connected to power. Sleep duration, pattern of and duration spent in different sleep stages (deep, REM, and light sleep), sleep latency, sleep efficiency, and sleep regularity. |
3 periods in total of 2 weeks each: weeks 1-2 , weeks 4-5, and weeks 7-8.
|
|
Sleep quality - sleep efficiency
Time Frame: 3 periods in total of 2 weeks each: weeks 1-2 , weeks 4-5, and weeks 7-8.
|
Objective sleep quality will be monitored with the Withings Sleep Analyzer (Withings, Issy-les-Moulineaux, France) . Prior to the study, the Withings Sleep Analyzer will be installed in the participants bed. A smart phone is required to set-up the device and the devices must be connected to a Wi-Fi to be able to send data to the cloud. After set-up no link to the smartphone is required. The device must be connected to power. Sleep duration, pattern of and duration spent in different sleep stages (deep, REM, and light sleep), sleep latency, sleep efficiency, and sleep regularity. |
3 periods in total of 2 weeks each: weeks 1-2 , weeks 4-5, and weeks 7-8.
|
|
Sleep quality - sleep regularity
Time Frame: 3 periods in total of 2 weeks each: weeks 1-2 , weeks 4-5, and weeks 7-8.
|
Objective sleep quality will be monitored with the Withings Sleep Analyzer (Withings, Issy-les-Moulineaux, France) . Prior to the study, the Withings Sleep Analyzer will be installed in the participants bed. A smart phone is required to set-up the device and the devices must be connected to a Wi-Fi to be able to send data to the cloud. After set-up no link to the smartphone is required. The device must be connected to power. Sleep duration, pattern of and duration spent in different sleep stages (deep, REM, and light sleep), sleep latency, sleep efficiency, and sleep regularity. |
3 periods in total of 2 weeks each: weeks 1-2 , weeks 4-5, and weeks 7-8.
|
|
Biological assessment: clock gene expression
Time Frame: 4 times in total: at baseline (3 weeks before start of the study), at the second , fifth, and eighth week
|
Paxgene 1x 2.5 ml 7,5 ml RNA Gene expression clock genes (in batch)
|
4 times in total: at baseline (3 weeks before start of the study), at the second , fifth, and eighth week
|
|
Biological assessment: metabolomics
Time Frame: 4 times in total: at baseline (3 weeks before start of the study), at the second , fifth, and eighth week
|
EDTA 1x 2 ml 6 ml plasma Metabolomics (in batch)
|
4 times in total: at baseline (3 weeks before start of the study), at the second , fifth, and eighth week
|
|
Biological assessment: proteomics
Time Frame: 4 times in total: at baseline (3 weeks before start of the study), at the second , fifth, and eighth week
|
EDTA 1x 2 ml 6 ml plasma proteomics (in batch)
|
4 times in total: at baseline (3 weeks before start of the study), at the second , fifth, and eighth week
|
|
Biological assessment: glucose metabolism
Time Frame: 4 times in total: at baseline (3 weeks before start of the study), at the second , fifth, and eighth week
|
EDTA 1x 2 ml 2 ml plasma HbA1c, Insulin, glucose,
|
4 times in total: at baseline (3 weeks before start of the study), at the second , fifth, and eighth week
|
|
Biological assessment: biomarkers for inflammation, thyroid, kidney and liver function
Time Frame: 4 times in total: at baseline (3 weeks before start of the study), at the second , fifth, and eighth week
|
Serum 1x 3.5 ml 14 ml serum eGRF/creatinin, Hs-CRP, Gamma GT, ASAT, ALAT, TSH, ft4 (in batch)
|
4 times in total: at baseline (3 weeks before start of the study), at the second , fifth, and eighth week
|
|
Food capturing
Time Frame: 3 periods in total of one week each: week two, week five, and at week eight.
|
Participants will log their daily food intake during each measurement week by using a food diary that will be distributed prior to the start of the study.
Frequency and timing of food intake will be assessed.
|
3 periods in total of one week each: week two, week five, and at week eight.
|
|
Heart rate
Time Frame: 3 periods in total of 2 weeks each: weeks 1-2 , weeks 4-5, and weeks 7-8.
|
Participants will wear the Corsano Cardiowatch 287-2 (Corsano Health, The Hague, the Netherlands) wrist band on their right wrist continuously during the study period.
The wristband is multifunctional and is waterproof.
Participants will wear the wrist band 24 hours a day.
The HR is measured using a PPG (photoplethysmogram, i.e., optically obtained volumetric measurement) and ECG.
The manufacturer supplies the algorithm for converting the PPG/ECG signals into a set of HR values.
All data from the Cardiowatch is available real time and is transferred from the watch to the smartphone using a clinical trial app, developed by the provider, which allows the researcher to retrieve live vital sign data while conducting a blinded study.
|
3 periods in total of 2 weeks each: weeks 1-2 , weeks 4-5, and weeks 7-8.
|
|
Heart rate variability
Time Frame: 3 periods in total of 2 weeks each: weeks 1-2 , weeks 4-5, and weeks 7-8.
|
Participants will wear the Corsano Cardiowatch 287-2 (Corsano Health, The Hague, the Netherlands) wrist band on their right wrist continuously during the study period.
The wristband is multifunctional and is waterproof.
Participants will wear the wrist band 24 hours a day.
The HR is measured using a PPG (photoplethysmogram, i.e., optically obtained volumetric measurement) and ECG.
The manufacturer supplies the algorithm for converting the PPG/ECG signals into a set of HR values.
All data from the Cardiowatch is available real time and is transferred from the watch to the smartphone using a clinical trial app, developed by the provider, which allows the researcher to retrieve live vital sign data while conducting a blinded study.
|
3 periods in total of 2 weeks each: weeks 1-2 , weeks 4-5, and weeks 7-8.
|
|
Core body temperature
Time Frame: 3 periods in total of 2 weeks each: weeks 1-2 , weeks 4-5, and weeks 7-8.
|
Core body temperature will be continuously measured by the Cardiowatch 287-2 in degrees Celcius.
This parameter will be derived through an algorhythm of combined data from Heatflux sensor and PPG signal.
Diurnal patterns of core body temperature as well as the time of lowest daily temperature will be derived from this data.
|
3 periods in total of 2 weeks each: weeks 1-2 , weeks 4-5, and weeks 7-8.
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Diana van Heemst, PhD, Leiden University Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NL82335.058.22
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.